Canadian Patent Awarded to SpectraScience

Medical device company SpectraScience Inc. of San Diego has received a Canadian patent for its optical biopsy system and methods for tissue diagnosis. The patent will provide protection of tissue surveillance, characterization, diagnosis and treatment. It will also support the company’s technology of noninvasive, low-level laser diagnosis of precancerous and cancerous tissue.





LATEST NEWS

• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024
• One-Step Hologram Generation Speeds 3D Display Creation
  Apr 24, 2024
• Innovation Award Winners for Laser Technology Honored in Aachen
  Apr 23, 2024
• Intech 2024: AI Arrives on the Shop Floor
  Apr 22, 2024